A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
“This is the first time that scientists have been able to create an AMD animal model that closely represents the disease in people,” said Stephen Rose, Ph.D., Chief Research Officer, Foundation Fighting Blindness. “Though there are some treatments for the wet form of AMD, we still don’t have a cure for the condition, and millions of people are still at risk of losing their vision to both the dry and wet forms. This new model will greatly enhance the development of better treatments and potentially a cure.”
Researchers at the Cleveland Clinic Lerner College of Medicine used oxidative chemicals to sensitize the immune systems in mice and create AMD . The study is titled “Oxidative damage-induced inflammation initiates age-related macular degeneration,” and was published in the online edition of the scientific journal Nature Medicine on January 27.
Once developed, therapies for the dry form, or early stage of AMD, could be implemented before vision is lost, which would be a dramatic breakthrough in the treatment of the disease, Rose said.
Source: Foundation Fighting Blindness
Related stories:
Case Western Reserve University gets $4 million to make 'smart nanoparticles'
The School of Medicine received $4 million in funding from the State of Ohio's Third Frontier Initiative for Targeted Nanoparticles for Imaging and Therapeutics (TNIP), which will support the development and commercialization of sub-atomic particles for the early detection of breast cancers and new therapies for hemophilia. Case Western Reserve University will work in collaboration with local companies Cleveland NanoCrystals, Copernicus Therapeutics, Inc., iMedd, Inc., and Ricera Biosciences, Inc. Principal investigator for TNIP is Pamela B. Davis, M.D., Ph.D., professor of pediatrics and senior associate dean for research at the School of Medicine.
Eating fish and foods with omega-3 fatty acids linked to lower risk of age-related eye disease
Eating fish and other foods high in omega-3 fatty acids is associated with reduced risk of the eye disease age-related macular degeneration (AMD), according to a meta-analysis of nine previously published studies in the June issue of
Archives of Ophthalmology. However, the accumulated evidence includes few clinical trials and is insufficient to support the routine consumption of such foods for AMD prevention, the authors note.
Cell's 'power plant' genes raise vision disorder risk
Genetic variation in the DNA of mitochondria – the “power plants” of cells – contributes to a person’s risk of developing age-related macular degeneration (AMD), Vanderbilt investigators report May 7 in the journal
PLoS ONE.
Physician revolutionizes gene research
A dramatic new study published in the most recent issue of
Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.
NSF-chartered Plane Crashes While Taking Off from Remote Antarctic Field Camp
A National Science Foundation (NSF)-chartered aircraft operating in Antarctica crashed shortly after take-off earlier this week while providing support to a group of researchers at a remote location on the southernmost continent. None of the 10 people aboard was injured, but the DC-3 Basler was severely damaged.
New treatment for age-related macular degeneration within sight
With 8 million people at high risk for advanced age-related macular degeneration, researchers from Harvard and Japan discovered that the experimental drug, endostatin, may be the cure. A research report published in the December 2007 issue of The FASEB Journal, describes how giving endostatin to mice significantly reduced or eliminated abnormal blood vessel growth within the eye, which is ultimately why the disease causes blindness.
Research team finds link between zinc and macular degeneration
A team of scientists, including three researchers at George Mason University, found that the mineral zinc could play a role in the development of macular degeneration. In studying eye tissue samples, the researches found that deposits, that are hallmarks of age-related macular degeneration (AMD), contain large amounts of zinc.
Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease, according to two reports in the May issue of
Archives of Ophthalmology.